BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 17152054)

  • 1. Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features.
    Goto M; Ito H; Akazawa K; Kubota T; Kizu O; Yamada K; Nishimura T
    J Magn Reson Imaging; 2007 Jan; 25(1):104-12. PubMed ID: 17152054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
    Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
    Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
    Schnall MD; Blume J; Bluemke DA; DeAngelis GA; DeBruhl N; Harms S; Heywang-Köbrunner SH; Hylton N; Kuhl CK; Pisano ED; Causer P; Schnitt SJ; Thickman D; Stelling CB; Weatherall PT; Lehman C; Gatsonis CA
    Radiology; 2006 Jan; 238(1):42-53. PubMed ID: 16373758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
    Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
    Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results.
    Pinker K; Grabner G; Bogner W; Gruber S; Szomolanyi P; Trattnig S; Heinz-Peer G; Weber M; Fitzal F; Pluschnig U; Rudas M; Helbich T
    Invest Radiol; 2009 Sep; 44(9):553-8. PubMed ID: 19652611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium-enhanced three-dimensional magnetization-prepared rapid gradient-echo (3D MP-RAGE) imaging is superior to spin-echo imaging in delineating brain metastases.
    Takeda T; Takeda A; Nagaoka T; Kunieda E; Takemasa K; Watanabe M; Hatou T; Oguro S; Katayama M
    Acta Radiol; 2008 Dec; 49(10):1167-73. PubMed ID: 18979271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
    Kuhl CK; Schild HH; Morakkabati N
    Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data.
    Woods BJ; Clymer BD; Kurc T; Heverhagen JT; Stevens R; Orsdemir A; Bulan O; Knopp MV
    J Magn Reson Imaging; 2007 Mar; 25(3):495-501. PubMed ID: 17279534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Kamitani T; Setoguchi T; Okafuji T; Soeda H; Sakai S; Hatakenaka M; Kubo M; Tokunaga E; Yamamoto H; Honda H
    Eur J Radiol; 2010 Jul; 75(1):e126-32. PubMed ID: 19796900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between lesion size and signal enhancement on subtraction fat-suppressed MR imaging of the breast.
    Cheung HS; Tse GM; Lai SY; Yeung DK
    Magn Reson Imaging; 2004 Nov; 22(9):1259-64. PubMed ID: 15607097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance mammography of invasive lobular versus ductal carcinoma: systematic comparison of 811 patients reveals high diagnostic accuracy irrespective of typing.
    Dietzel M; Baltzer PA; Vag T; Gröschel T; Gajda M; Camara O; Kaiser WA
    J Comput Assist Tomogr; 2010 Jul; 34(4):587-95. PubMed ID: 20657229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
    Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
    Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
    Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
    Gokalp G; Topal U; Yildirim N; Tolunay S
    Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.
    Hauth EA; Jaeger HJ; Maderwald S; Muehler A; Kimmig R; Forsting M
    Eur J Radiol; 2008 May; 66(2):300-8. PubMed ID: 17658235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis.
    Yuen S; Uematsu T; Kasami M; Tanaka K; Kimura K; Sanuki J; Uchida Y; Furukawa H
    J Magn Reson Imaging; 2007 Mar; 25(3):502-10. PubMed ID: 17326093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.